Israeli vaccine gains support

Israel’s Migal Galilee Research Institute is now MigVax Corp and has just received $12 million of funds, led by Ourcrowd. MigVax is developing a safe, oral vaccine with 3 levels of protection. It will be easy to scale up and can be adjusted for other coronavirus strains.

This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *